Expression of Epstein-Barr virus latent membrane proteins leads to changes in keratinocyte cell adhesion

被引:15
作者
Farwell, DG
McDougall, JK
Coltrera, MD
机构
[1] Univ Washington, Dept Otolaryngol Head & Neck Surg, Sch Med, Seattle, WA 98195 USA
[2] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA
关键词
cell adhesion molecules; Epstein-Barr virus; immunocytochemistry; latent membrane proteins;
D O I
10.1177/000348949910800906
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Epstein-Barr virus (EBV) has 3 latent membrane proteins (LMPs)- LMP1, LMP2a, and LMP2b - which are expressed in nasopharyngeal carcinoma. Using keratinocyte cell lines expressing LMP2a and LMP2b and coexpressing LMP1/LMP2a, we grew organotypic raft cultures to analyze changes in morphology and expression of the cell adhesion molecule ICAM-1; alpha 2, alpha 3, alpha 5, beta 1, and alpha 6 beta 4 integrins; laminin 5; E-cadherin; and desmoplakin. Cells expressing LMP2a or LMP2b were defective in their ability to mature and progress through normal squamous stratification when compared to the parental cell lines. Cells coexpressing LMP1/LMP2a additionally demonstrated "pseudoinvasion" into the raft dermal equivalent. There was a consistent and dramatic up-regulation in the suprabasal expression of laminin 5 and alpha 6 beta 4 and beta 1 integrins in the LMP-expressing cell lines. ICAM-1, not expressed in the control cell lines, was up-regulated in the LMP-expressing cell lines. Expression of alpha 3 and alpha 5 integrins was also up-regulated in the LMP-expressing cell lines, while alpha 2 demonstrated a loss of the normal basal layer expression. E-cadherin and desmoplakin expression patterns were essentially unchanged. We conclude that LMP2a and LMP2b singly, and LMP1/LMP2a coexpressed, are capable of altering keratinocyte cell adhesion molecule expression consistent with nasopharyngeal carcinoma.
引用
收藏
页码:851 / 859
页数:9
相关论文
共 50 条
[21]   Doxycycline dependent expression of Epstein-Barr virus latent membrane protein 1 with Tet regulating system in nasopharygeal carcinoma cell line [J].
Liao, W ;
Yi, H ;
Li, XY ;
Tang, M ;
Gu, HH ;
Cao, Y .
ACTA BIOCHIMICA ET BIOPHYSICA SINICA, 1999, 31 (03) :309-312
[22]   Rescue of the immunotherapeutic potential of a novel T cell epitope in the Epstein-Barr virus latent membrane protein 2 [J].
Lalonde, Annick ;
Avila-Carino, Javier ;
Caruso, Manuel ;
de Campos-Lima, Pedro O. .
VIROLOGY, 2007, 361 (02) :253-262
[23]   The association of latent Epstein-Barr virus infection with hydroa vacciniforme [J].
Iwatsuki, K ;
Xu, Z ;
Takata, M ;
Iguchi, M ;
Ohtsuka, M ;
Akiba, H ;
Mitsuhashi, Y ;
Takenoshita, H ;
Sugiuchi, R ;
Tagami, H ;
Kaneko, F .
BRITISH JOURNAL OF DERMATOLOGY, 1999, 140 (04) :715-721
[24]   Epstein-Barr Virus: The Path from Latent to Productive Infection [J].
Chiu, Ya-Fang ;
Sugden, Bill .
ANNUAL REVIEW OF VIROLOGY, VOL 3, 2016, 3 :359-372
[25]   Epstein-Barr virus and oncogenesis: from latent genes to tumours [J].
Young, LS ;
Murray, PG .
ONCOGENE, 2003, 22 (33) :5108-5121
[26]   The influence of psychological stress on immunoregulation of latent Epstein-Barr virus [J].
Benschop, RJ ;
Jabaaij, L ;
Oostveen, FG ;
Vingerhoets, AJJM ;
Ballieux, RE .
STRESS MEDICINE, 1998, 14 (01) :21-29
[27]   Epithelial cell infection by Epstein-Barr virus [J].
Chen, Jia ;
Longnecker, Richard .
FEMS MICROBIOLOGY REVIEWS, 2019, 43 (06) :674-683
[28]   Epstein-Barr virus in Burkitt's lymphoma A role for latent membrane protein 2A [J].
Bieging, Kathryn T. ;
Swanson-Mungerson, Michelle ;
Amick, Alexandra C. ;
Longnecker, Richard .
CELL CYCLE, 2010, 9 (05) :901-908
[29]   Latent membrane protein 1 of Epstein-Barr virus mimics a constitutively active receptor molecule [J].
Gires, O ;
ZimberStrobl, U ;
Gonnella, R ;
Ueffing, M ;
Marschall, G ;
Zeidler, R ;
Pich, D ;
Hammerschmidt, W .
EMBO JOURNAL, 1997, 16 (20) :6131-6140
[30]   Promotion of metastasis in nasopharyngeal carcinoma by Epstein-Barr virus latent membrane protein-1 [J].
Yoshizaki, T .
HISTOLOGY AND HISTOPATHOLOGY, 2002, 17 (03) :845-850